United States · FDA National Drug Code directory
topiramate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-7351_51166b3d-4021-4018-9ea5-c2d159023c27
- Product NDC
- 68788-7351
- Form
- TABLET, FILM COATED
- Composition / generic term
- topiramate
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190227
- Source listing expiry
- 20261231
Source-listed ingredients
- TOPIRAMATE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (68788-7351-1) · 68788-7351-1
- 30 TABLET, FILM COATED in 1 BOTTLE (68788-7351-3) · 68788-7351-3
- 15 TABLET, FILM COATED in 1 BOTTLE (68788-7351-5) · 68788-7351-5
- 60 TABLET, FILM COATED in 1 BOTTLE (68788-7351-6) · 68788-7351-6
- 90 TABLET, FILM COATED in 1 BOTTLE (68788-7351-9) · 68788-7351-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →